Storen Legacy Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Buy
991
+215
+28% +$59.5K 0.06% 103
2026
Q1
$229K Hold
776
0.07% 96
2025
Q4
$212K Buy
+776
New +$211K 0.07% 71

Other funds holding CME

Storen Legacy Partners's CME Position: Q2 2026 in Review

Storen Legacy Partners increased its CME Group (CME) stake by 28% in Q2 2026, buying an estimated $59.5K and bringing the position to 991 shares worth $219K. The position accounts for 0.06% of the portfolio, ranked #103.

Storen Legacy Partners first reported a position in CME in Q4 2025 and has held it in 3 quarters since. The position peaked at $229K in Q1 2026. 1,693 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Storen Legacy Partners held 991 shares of CME Group worth $219K as of Q2 2026.
  • Storen Legacy Partners bought 215 CME Group shares in Q2 2026, an estimated $59.5K.
  • CME Group made up 0.06% of Storen Legacy Partners's portfolio in Q2 2026, its #103 holding.
  • Storen Legacy Partners first reported a position in CME Group in Q4 2025 and has held it in 3 quarters since.
  • Storen Legacy Partners's CME Group position peaked at $229K in Q1 2026.
  • 1,693 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Storen Legacy Partners's 13F filing for Q2 2026, filed 17 Jul 2026.